Prime Medicine Inc. held a virtual special meeting of stockholders on August 1, 2025. During the meeting, stockholders voted to approve a one-time repricing of certain outstanding stock options held by current employees, including executive officers and board members. Additionally, a proposal to adjourn the meeting to a later date, if necessary, was approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prime Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-037840), on August 05, 2025, and is solely responsible for the information contained therein.